Term ends Aug 6, 2031 · High confidence
20-year base term ends Sep 28, 2029
Held by Societe des Produits Nestle S.A.
Filed Sep 28, 2009 as application 12/568,064 · Granted Jul 22, 2014
Base term plus 677 days of patent term adjustment (USPTO delay)
Today
2009
2031
Clock starts
Sep 28, 2009
Sep 28, 2009
Term ends
Aug 6, 2031
Aug 6, 2031
Granted
Jul 22, 2014
Jul 22, 2014
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
677
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
28
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 677 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 28, 2009, when this application, 12/568,064, was filed | Sep 28, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +677 days, USPTO patent term adjustment record | Aug 6, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 6, 2031 | High confidence |
This family
| US 8,604,222 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,246,950 | In force Feb 2028 | Feb 2028 |
| US 8,221,747 | In force Feb 2028 | Feb 2028 |
| US 8,293,229 | In force Mar 2031 | Mar 2031 |
| US 7,541,384 | In force Jun 2028 | Jun 2028 |
| US 10,087,493 | In force Mar 2029 | Mar 2029 |
| US 8,217,083 | In force Jun 2028 | Jun 2028 |
| US 8,784,884 | this patent Aug 2031 | Aug 2031 |
8 of 28 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 14, 2010 Reel 23784, frame 303 | Eurand, Inc. | Eurand Pharmaceuticals, Limited | Assignment of Assignor's Interest |
| Jan 14, 2010 Reel 23784, frame 460 | Eurand Pharmaceuticals, Inc. | Eurand Pharmaceuticals Limited | Assignment of Assignor's Interest |
| Jan 14, 2010 Reel 23784, frame 484 | Perrett, Stephen; Thieroff-ekerdt, Ruth | Eurand Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 14, 2010 Reel 23784, frame 597 | Efthymiopoulos, Konstantinos | Eurand Pharmaceuticals Limited | Assignment of Assignor's Interest |
| Jan 14, 2010 Reel 23784, frame 535 | Venkatesh, Gopi | Eurand, Inc. | Assignment of Assignor's Interest |
| Apr 2, 2015 Reel 35317, frame 1 | Eurand Pharmaceuticals Limited | Aptalis Pharma Limited | Change of Name |
| Jul 15, 2015 Reel 36092, frame 964 | Venkatesh, Gopi | Eurand Inc. | Assignment of Assignor's Interest |
| Jul 15, 2015 Reel 36093, frame 121 | Venkatesh, Gopi | Eurand Pharmaceuticals Limited | Assignment of Assignor's Interest |
| Jul 15, 2015 Reel 36093, frame 499 | Eurand Pharmaceuticals Limited | Aptalis Pharma Limited | Change of Name |
| Mar 18, 2016 Reel 38177, frame 967 | Aptalis Pharma Limited | Allergan Pharmaceuticals International Limited | Change of Name |
| Apr 30, 2020 Reel 52538, frame 196 | Allergan Pharmaceuticals International Limited | Allergan Therapeutics LLC | Assignment of Assignor's Interest |
| Jul 9, 2020 Reel 53164, frame 711 | Allergan Therapeutics LLC | Societe des Produits Nestle S.A. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2031
Term ends Aug 6, 2031. No further fees fall due before then
Note
The 677 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
8
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.